67
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]

Pages 247-248 | Published online: 03 Feb 2020

Figures & data

Figure 3 Kaplan–Meier survival curves evaluating the time to death in days for patients with NT-proBNP concentrations ≥551.35 ng/L and NT-proBNP concentrations <551.35 ng/L. Panel A: survival curve for all patients; Panel B: survival curve for patients with CHF; Panel C: survival curve for patients without CHF.

Abbreviation: CHF, congestive heart failure.
Figure 3 Kaplan–Meier survival curves evaluating the time to death in days for patients with NT-proBNP concentrations ≥551.35 ng/L and NT-proBNP concentrations <551.35 ng/L. Panel A: survival curve for all patients; Panel B: survival curve for patients with CHF; Panel C: survival curve for patients without CHF.